Developmental Changes in Soluble CD40 Ligand

Journal of Pediatrics

Volumn 152, Issue 1, 2008, Pages

  Cholette, Jill M ^a   Blumberg, Neil ^a   Phipps, Richard P ^a   McDermott, Michael P ^a   Gettings, Kelly F ^a   Lerner, Norma B ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND;

ADOLESCENT; ADULT; ARTICLE; BIRTH; CHILD; CHILDHOOD; COMPARATIVE STUDY; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HUMAN; INFANT; MALE; NEWBORN; PEDIATRICS; POPULATION; PRIORITY JOURNAL; RANK SUM TEST; STATISTICAL SIGNIFICANCE;

EID: 37249035599     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.06.036     Document Type: Article

References (30)

1. Inwald D.P., McDowall A., Peters M.J., Callard R.E., and Klein N.J. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 92 (2003) 1041-1048
2. Phipps R.P. Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. PNAS 97 (2000) 6930-6932
3. Andre P., Nannizzi-Alaimo L., Prasad S.K., and Phillips D.R. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106 (2002) 896-899
4. Wagner D.D. New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol 25 (2005) 1321-1324
5. Henn V., Slupsky J.R., Grafe M., Anagnostopoulos I., Forster R., Muller-Berghaus G., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391 (1998) 591-593
6. Henn V., Steinbach S., Bucher K., Presek P., and Kroczek R.A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporarily limited by coexpression CD40. Blood 98 (2001) 1047-1054
7. Kaufman J., Sime P.J., and Phipps R.P. Expression of CD154 (CD40 ligand) by human lung fibroblasts: differential regulation by IFN-gamma and IL-13, and implications for fibrosis. J Immunol 172 (2004) 1862-1871
8. Schonbeck U., Mach F., Sukhova G.K., Herman M., Graber P., Kehry M.R., et al. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am J Pathol 156 (2000) 7-14
9. Heeschen C., Dimmeler S., Hamm C.W., van den Brand M.J., Boersma E., Zeiher A.M., et al. Soluble CD40 ligand in acute coronary sundromes. N Engl J Med 348 (2003) 1104-1111
10. Andre P., Prasad K.S., Denis C.V., He M., Papalia J.M., Hynes R.O., et al. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 8 (2002) 247-252
11. Leveille C., Bouillon M., Guo W., Bolduc J., Sharif-Askari E., El-Fakhry Y., et al. CD40 ligand binds to α5β1 integrin and triggers cell signaling. J Biol Chem 282 (2007) 5143-5151
12. Aukrust P., Damas J.K., and Solum N.O. Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation?. J Am Coll Cardiol 43 (2004) 2326-2328
13. Garlichs C.D., Eskafi S., Raaz D., Schmidt A., Ludwig J., Herrmann M., et al. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. Heart 86 (2001) 649-655
14. Schonbeck U., Varo N., Libby P., Buring J., and Ridker P.M. Soluble CD40L and cardiovascular risk in women. Circulation 104 (2001) 2266-2268
15. Lee S.P., Ataga K.I., Orringer E.P., Philliips D.R., and Parise L.V. Biologically active CD40 ligand is elevated in sickle cell anemia. Potential role for platelet-mediated inflammation. Thromb Vasc Biol 26 (2006) 1626-1631
16. Kato K., Santana-Sahagun E., Rassenti L.Z., Weisman M.H., Tamura N., Kobayashi S., et al. The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J Clin Invest 104 (1999) 947-955
17. Tamura T., Kobayashi S., Kato K., Bando H., Haruta K., Oyanagi M., et al. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis. J Rheumatol 28 (2001) 2583-2590
18. Damas J.K., Otterdal K., Yndestad A., Aass H., Solum N.O., Froland S.S., et al. Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells. Circulation 110 (2004) 999-1005
19. Nannizzi-Alaimo L., Rubenstein M.H., Alves V.L., Leong G.Y., Phillips D.R., and Gold H.K. Cardiopulmonary bypass induces release of soluble CD40 ligand. Circulation 105 (2002) 2849-2854
20. Cipollone F., Ferri C., Desideri G., Paloscia L., Materazzo G., Mascellanti M., et al. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation 108 (2003) 2776-2782
21. Khan S.Y., Kelher M.R., Heal J.M., Blumberg N., Boshkov L.K., Phipps R.P., et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40 and is a cofactor in the development of transfusion-related acute lung injury. Blood 108 (2006) 2455-2462
22. Israels S.J., and Michelson A.D. Antiplatelet therapy in children. Thromb Res 118 (2006) 75-83
23. Israels S.J., Cheang T., McMillan-Ward E.M., and Cheang M. Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatr 138 (2001) 116-119
24. Monagle P., Barnes C., Ignjatovic V., Furmedge J., Newall F., Chan A., et al. Developmental haemostasis: impact for clinical haemostasis laboratories. Thromb Haemost 95 (2006) 362-372
25. Ishiguro A., Nakahata T., Matsubara K., Hayashi Y., Kato T., Suzuki Y., et al. Age-related changes in thrombopoietin in children: reference interval for serum thrombopoietin levels. Br J Haematol 106 (1999) 884-888
26. Viallard J.F., Solanilla A., Gauthier B., Contin C., Dechanet J., Grosset C., et al. Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood 99 (2002) 2612-2614
27. Mason P.J., Chakrabarti S., Albers A.A., Rex S., Vitseva O., Varghese S., et al. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease. Am J Cardiol 96 (2005) 1365-1369
28. Conde I.D., and Kleiman N.S. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348 (2003) 2575-2577
29. Bereczki D., Nagy E., Pal A., Magyar M.T., and Balla J. Should soluble CD40 ligand be measured from serum or plasma samples?. Arterioscler Thromb Vasc Biol 23 (2003) 1129-1130
30. Blake G.J., Otsfeld R.J., Yucel E.K., Varo N., Schonbeck U., Blake M.A., et al. In response to: should soluble CD40 ligand be measured from serum or plasma samples?. Arterioscler Thromb Vasc Biol 23 (2003) 1130-1131